Feb 26, 2014; Port St Lucie, FL, USA; New York Mets Bartolo Colon poses during media day at Tradition Field. Mandatory Credit: Brad Barr-USA TODAY Sports

WIll The Mets Regret Signing Colon?


With Matt Harvey down for the 2014 season, Sandy Alderson signed Bartolo Colon in December, with the hope that the 40-year-old could be a top-of-the-rotation starter. Colon has yet to appear in grapefruit league action due to a sore calf muscle (he is expected to start his first game Monday). While it’s far too early to assess Alderson’s $20 million investment, it isn’t too early to discuss its implications.

Let’s start with this-did Alderson jump the gun in signing Colon? Perhaps he did. The Mets are deep in starting pitching, going into 2014 with Jonathon Niese, Zack Wheeler, Dillon Gee, Jenrry Mejia, Daisuke Matsuzaka, John Lannan, and young candidates Noah Syndergaard, Rafael Montero, and Jacob deGrom. While Matsuzaka and Lannan were not in the organization when Colon was signed, they and other less-expensive options were available on the market.

Essentially, Alderson added to an organizational strength with a pitcher who, at age 40, was coming off of a very strong year with Oakland. It cost Alderson $10 million to do this. Did he “buy high”? In addition, Alderson, in my estimation, took quite a gamble that Colon can come close to the success of his 2013 campaign at age 41, and in a new league. We may already be seeing the effects of Colon’s age and physical condition in his calf injury. One has to wonder if the added dimension of having to hit in the National League could make staying healthy more difficult for Colon.

Then there are the financial implications of signing Colon. The Mets are (hopefully) emerging from severe financial restrictions. However, their payroll is projected at $87 million (with incentives), and they’ve stated that they will not be adding to it significantly. It is clear that signing Colon has limited the Mets’ ability to sign Stephen Drew, who could address a large hole in their lineup. Yes, Drew’s demands are not commensurate with his potential contributions. However, it’s reasonable that 2 years/$20 million could bring him to Queens (especially with his prolonged hold out). The signing of Colon is a very limiting factor in the Mets’ ability to engage Drew at this level.

The point is that there may have been internal options to add a starting pitcher. Mets fans are understandably excited about seeing Montero and Syndergaard. If the Mets had decided to give Montero a shot (as a fourth starter) and gone with the winner of Mejia/Lannan/Dice-K as the fifth starter, I’d argue that the rotation may not have been significantly less effective than with Colon, if at all. The cost savings could have gone to Drew. The early returns on Ruben Tejada are not good. It’s certainly possible the Mets could trade for a shortstop. However, that will likely cost one of the young arms referenced above. If it were up to me, I’d keep the young arms, give them a shot, and would have spent those $20 million on Stephen Drew.

Thanks for reading! Be sure to follow@RisingAppleBlog on Twitter and Instagram, and Like Rising Apple’s Facebook page to keep up with the latest news, rumors, and opinion.

Next Mets Game View full schedule »
Friday, Aug 2929 Aug7:10Philadelphia PhilliesBuy Tickets

Tags: Bartolo Colon Noah Syndergaard Rafael Montero Ruben Tejada Stephen Drew

  • roger roger

    I think it was a great, no-brainer signing that is pretty low risk. First, it is NOT a new league for Colon because he pitched for the Expos under Omar Minaya. So, maybe it’s been a while, but it’s not new.

    Second, a calf injury is a calf injury. Why does it have to be indicative of age?

    The Mets would have a totally different, AAA-outlook to them this year without Colon. Yes, there is risk associated with the signing if he finally breaks down. If he’s healthy, though, chances are he’ll perform and the Mets will get an 18-game winner with a 2-point-something ERA for $10M a year. I’m sorry, but that’s about as smart a signing as I’ve seen in years by the Mets. Colon actually gives them a chance to make the playoffs, if he can stay healthy. It’s a great signing, period.

  • roger roger

    oh, and also – let’s say Colon goes out and pitches decently but the Mets are out of it by August. they can trade him (if he passes through waivers) to a contender, or in the off season, for a potentially valuable asset, because of his relatively low-risk contract. The main risk is if his clock suddenly expires out of nowhere, which seems unlikely given how well he’s pitched the past few years.

  • Eric Kench

    Although I don’t really like the Colon signing Drew is not worth the money that he’s asking for. Plain and simple.